ONWARD – Developing neurostimulation to treat patients suffering from spinal cord injury
ONWARD's breakthrough developments will help people with spinal cord injury to regain voluntary as well as autonomic body functions and to enjoy life in every way that matters to them.
ONWARD is developing neurostimulation systems called ARC Therapy, to treat patients suffering from spinal cord injury. ARC Therapy is designed to deliver targeted, programmed stimulation of the spinal cord to restore movement and other non-voluntary functions. The science behind ONWARD has been developed with rigor and patience at renowned institutes such as the Center for Neuroprosthetics of the École polytechnique fédérale de Lausanne in Switzerland, and is reinforced by multiple peer-reviewed publications in the world’s most respected scientific journals.
Industry
Medical Devices
